BIO-FD&C Co.,Ltd. (KOSDAQ:251120)
South Korea · Delayed Price · Currency is KRW 9,170.00
+370.00 (4.20%)
At close: Sep 23, 2026
BIO-FD&C Market Cap
BIO-FD&C has a market cap or net worth of 79.74 billion as of September 25, 2026. Its market cap has decreased by -50.08% in one year.
Market Cap
79.74B
Enterprise Value
24.49B
Revenue
19.53B
Ranking
n/a
PE Ratio
12.22
Stock Price
9,170.00
ChartMarket Cap Chart
Since February 21, 2022, BIO-FD&C's market cap has decreased from 193.04B to 79.74B, a decrease of -58.69%. That is a compound annual growth rate of -17.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 79.74B | -41.96% |
| Dec 30, 2025 | 137.39B | 14.33% |
| Dec 30, 2024 | 120.17B | -2.12% |
| Dec 28, 2023 | 122.78B | -16.94% |
| Dec 29, 2022 | 147.83B | -23.42% |
| Feb 21, 2022 | 193.04B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cell Biotech | 102.11B |
| AriBioLab | 98.47B |
| CORESTEMCHEMON | 94.27B |
| Choong Ang Vaccine Laboratory | 84.70B |
| EyeGene | 84.30B |
| Naturalendo Tech | 74.67B |
| CTCBIO | 71.85B |
| IMGT Co.,Ltd. | 69.86B |